AMGN · Verdict

A summary of rules, not a profit forecast — don’t buy just because of a green verdict.

• ▼ P/E 28.9 — expensive for this stock (over 10 y: from 14.3 to 64.6)
• ▲ P/E 28.9 vs peer median 46.0 — cheaper than peers
• ▼ P/S 6.6 — expensive for this stock (over 10 y: from 4.2 to 6.3)
• ▼ EV/EBITDA 17.1 — expensive for this stock (over 10 y: from 11.9 to 14.4)
• ▲ EV/EBITDA 17.1 vs peer median 22.9 — cheaper than peers
• ▼ FCF yield 3.2% — expensive for this stock (over 10 y: from 4.6% to 8.7%)
• ▲ FCF yield 3.2% vs peer median 2.8% — cheaper than peers
• ▲ Forward P/E 19.0 is below the current one — earnings growth expected

• ▲ Has raised its dividend 14 years in a row
• ▲ Piotroski 7/9 — strong financial health
• ▲ ROE 91% — high return on equity
• ▼ Net margin fell: 24.9% → 21.0%
• ▼ Debt / equity 6.31 — heavy debt load
• ▲ Free cash flow positive every year

• ▲ Analysts raised the earnings forecast by +3.0% in 90 days

• ▲ Over 6 mo stronger than its sector (XLV) by 8%
• ▲ Price above SMA200 — long-term uptrend
• ▲ SMA50 above SMA200 — trend up
• ▲ Over a year +60% vs S&P 500 +11% — stronger than the market

• ▼ Earnings in 1 d — the price may move sharply (≈ ±4.7%)
• ▼ Volatility 30% per year — much higher than the market (13%)

• ▼ Mean analyst target -15% from the current price
• ▲ Insiders buying over 6 mo

• ▲ S&P 500 above SMA200 — the market is in an uptrend
• ▲ Sector (XLV) above SMA200 — in an uptrend
• ▲ Sector (XLV) over 3 mo is stronger than the market by 11%